VP, Medical Affairs – Hematology-Oncology
Nurix Therapeutics
June 30, 2026
Remote friendly (Brisbane, CA)
United States
Medical Affairs
Position Overview
- Build, expand, and lead a best-in-class Medical Affairs organization supporting transition from clinical stage to commercialization for hematology-oncology programs.
- Provide strategic and operational leadership across medical strategy, field medical, scientific communications, evidence generation, thought leader engagement, medical information, and launch readiness.
- Partner cross-functionally with Clinical Development, Commercial, Market Access, Regulatory, Legal, and Compliance; contribute to portfolio strategy and lifecycle planning as a senior leader.
Key Responsibilities
- Lead and scale Medical Affairs for late-stage development and future commercial readiness.
- Own Medical Affairs strategy for the hematology-oncology portfolio.
- Develop the scientific platform and differentiated medical narrative.
- Partner with Clinical Development on late-stage medical strategy and lifecycle opportunities.
- Develop and execute integrated medical plans (field medical, publications, medical education, medical information, insight gathering, evidence generation).
- Expand and lead an MSL organization for compliant insight capture and credible scientific exchange.
- Lead external engagement (advisory boards, investigators, thought leaders, cooperative groups).
- Serve as a senior medical representative.
- Direct publication and scientific communication strategy.
- Lead integrated evidence generation (registrational support, post-marketing, RWE, HEOR, sequencing, differentiation).
- Partner with Commercial/Market Access to inform launch readiness and access planning.
- Monitor the hematology-oncology landscape and translate insights into strategy.
- Ensure Medical Affairs activities comply with legal/regulatory/company standards (in the role context).
- Provide medical/scientific leadership for executive governance on portfolio and commercialization readiness.
- Support global Medical Affairs planning and coordination.
Qualifications
- MD, PhD, DO, or PharmD required; oncology/hematology experience.
- 15+ years biopharmaceutical Medical Affairs leadership with accountability for launch and post-approval.
- Demonstrated leadership in late-stage hematology-oncology development and commercialization.
- Expertise in evidence generation (Phase 3b/4, RWE, HEOR), scientific communications, MSL leadership, and cross-functional launch planning.
- Strong understanding of global and US regulatory, compliance, and payer environments for medical activities.
- Experience with innovative therapeutic platforms; first-in-class mechanisms or rapidly evolving landscapes preferred.
- Excellent leadership, communication, collaboration; hands-on in fast-moving pre-commercial/launch environments.
- Experience building and scaling Medical Affairs organizations in emerging biotechnology/growth-stage settings preferred.
- Build, expand, and lead a best-in-class Medical Affairs organization supporting transition from clinical stage to commercialization for hematology-oncology programs.
- Provide strategic and operational leadership across medical strategy, field medical, scientific communications, evidence generation, thought leader engagement, medical information, and launch readiness.
- Partner cross-functionally with Clinical Development, Commercial, Market Access, Regulatory, Legal, and Compliance; contribute to portfolio strategy and lifecycle planning as a senior leader.
Key Responsibilities
- Lead and scale Medical Affairs for late-stage development and future commercial readiness.
- Own Medical Affairs strategy for the hematology-oncology portfolio.
- Develop the scientific platform and differentiated medical narrative.
- Partner with Clinical Development on late-stage medical strategy and lifecycle opportunities.
- Develop and execute integrated medical plans (field medical, publications, medical education, medical information, insight gathering, evidence generation).
- Expand and lead an MSL organization for compliant insight capture and credible scientific exchange.
- Lead external engagement (advisory boards, investigators, thought leaders, cooperative groups).
- Serve as a senior medical representative.
- Direct publication and scientific communication strategy.
- Lead integrated evidence generation (registrational support, post-marketing, RWE, HEOR, sequencing, differentiation).
- Partner with Commercial/Market Access to inform launch readiness and access planning.
- Monitor the hematology-oncology landscape and translate insights into strategy.
- Ensure Medical Affairs activities comply with legal/regulatory/company standards (in the role context).
- Provide medical/scientific leadership for executive governance on portfolio and commercialization readiness.
- Support global Medical Affairs planning and coordination.
Qualifications
- MD, PhD, DO, or PharmD required; oncology/hematology experience.
- 15+ years biopharmaceutical Medical Affairs leadership with accountability for launch and post-approval.
- Demonstrated leadership in late-stage hematology-oncology development and commercialization.
- Expertise in evidence generation (Phase 3b/4, RWE, HEOR), scientific communications, MSL leadership, and cross-functional launch planning.
- Strong understanding of global and US regulatory, compliance, and payer environments for medical activities.
- Experience with innovative therapeutic platforms; first-in-class mechanisms or rapidly evolving landscapes preferred.
- Excellent leadership, communication, collaboration; hands-on in fast-moving pre-commercial/launch environments.
- Experience building and scaling Medical Affairs organizations in emerging biotechnology/growth-stage settings preferred.